202 related articles for article (PubMed ID: 25534449)
1. Differential rates of ischemic cholangiopathy and graft survival associated with induction therapy in DCD liver transplantation.
Halldorson JB; Bakthavatsalam R; Montenovo M; Dick A; Rayhill S; Perkins J; Reyes J
Am J Transplant; 2015 Jan; 15(1):251-8. PubMed ID: 25534449
[TBL] [Abstract][Full Text] [Related]
2. Anti-thymocyte globulin versus basiliximab induction in renal transplant recipients: Long-term outcome.
Kesiraju S; Paritala P; Rao Ch UM; Athmakuri SM; Reddy VS; Sahariah S
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):9-15. PubMed ID: 24434376
[TBL] [Abstract][Full Text] [Related]
3. A retrospective comparison of the efficacy and safety in kidney transplant recipients with basiliximab and anti-thymocyte globulin.
Wang W; Yin H; Li XB; Hu XP; Yang XY; Liu H; Ren L; Wang Y; Zhang XD
Chin Med J (Engl); 2012 Mar; 125(6):1135-40. PubMed ID: 22613543
[TBL] [Abstract][Full Text] [Related]
4. Induction Immunosuppressive Therapy Use in Deceased Donor Kidney Transplantation: 11-Year Experience in Veracruz, Mexico.
Martinez-Mier G; Soto-Miranda E; Avila-Pardo SF; Budar-Fernandez LF; Mateu-Rivera LJ; Mendez-Lopez MT; Trujillo-Martinez MF; Uscanga-Montesano A; Avila Y Falfan D
Transplant Proc; 2016 Mar; 48(2):600-4. PubMed ID: 27110011
[TBL] [Abstract][Full Text] [Related]
5. Comparison of basiliximab vs antithymocyte globulin for induction in pediatric heart transplant recipients: An analysis of the International Society for Heart and Lung Transplantation database.
Butts RJ; Dipchand AI; Sutcliffe D; Bano M; Dimas V; Morrow R; Das B; Kirk R
Pediatr Transplant; 2018 Jun; 22(4):e13190. PubMed ID: 29878688
[TBL] [Abstract][Full Text] [Related]
6. Rabbit antithymocyte globulin compared with basiliximab in kidney transplantation: a single-center study.
Kim JM; Jang HR; Kwon CH; Huh WS; Kim GS; Kim SJ; Joh JW; Oh HY
Transplant Proc; 2012 Jan; 44(1):167-70. PubMed ID: 22310606
[TBL] [Abstract][Full Text] [Related]
7. Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab.
Ansari D; Lund LH; Stehlik J; Andersson B; Höglund P; Edwards L; Nilsson J
J Heart Lung Transplant; 2015 Oct; 34(10):1283-91. PubMed ID: 26087667
[TBL] [Abstract][Full Text] [Related]
8. Rabbit antithymocyte globulin versus basiliximab in renal transplantation.
Brennan DC; Daller JA; Lake KD; Cibrik D; Del Castillo D;
N Engl J Med; 2006 Nov; 355(19):1967-77. PubMed ID: 17093248
[TBL] [Abstract][Full Text] [Related]
9. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center.
Foley DP; Fernandez LA; Leverson G; Anderson M; Mezrich J; Sollinger HW; D'Alessandro A
Ann Surg; 2011 Apr; 253(4):817-25. PubMed ID: 21475025
[TBL] [Abstract][Full Text] [Related]
10. Assessment of immunosuppression induction with basiliximab compared to antithymocyte-globulin in adult heart transplant patients.
Eberhardt TE; Kim DH; Nethersole S; Pearson GJ
Clin Transplant; 2024 Jun; 38(6):e15332. PubMed ID: 38804609
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants.
Lentine KL; Schnitzler MA; Xiao H; Brennan DC
Trials; 2015 Aug; 16():365. PubMed ID: 26285695
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of ATG vs. Basiliximab induction.
Ulrich F; Niedzwiecki S; Pascher A; Kohler S; Weiss S; Fikatas P; Schumacher G; May G; Reinke P; Neuhaus P; Tullius SG; Pratschke J
Eur J Clin Invest; 2011 Sep; 41(9):971-8. PubMed ID: 21382021
[TBL] [Abstract][Full Text] [Related]
13. Induction therapy in simultaneous pancreas-kidney transplantation: thymoglobulin versus basiliximab.
Fernández-Burgos I; Montiel Casado MC; Pérez-Daga JA; Aranda-Narváez JM; Sánchez-Pérez B; León-Díaz FJ; Cabello-Díaz M; Rodríguez-Burgos D; Hernández-Marrero D; Santoyo-Santoyo J
Transplant Proc; 2015; 47(1):120-2. PubMed ID: 25645787
[TBL] [Abstract][Full Text] [Related]
14. Thymoglobulin versus basiliximab induction therapy for simultaneous kidney-pancreas transplantation: impact on rejection, graft function, and long-term outcome.
Bazerbachi F; Selzner M; Boehnert MU; Marquez MA; Norgate A; McGilvray ID; Schiff J; Cattral MS
Transplantation; 2011 Nov; 92(9):1039-43. PubMed ID: 22002345
[TBL] [Abstract][Full Text] [Related]
15. Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.
Thomusch O; Wiesener M; Opgenoorth M; Pascher A; Woitas RP; Witzke O; Jaenigen B; Rentsch M; Wolters H; Rath T; Cingöz T; Benck U; Banas B; Hugo C
Lancet; 2016 Dec; 388(10063):3006-3016. PubMed ID: 27871759
[TBL] [Abstract][Full Text] [Related]
16. Can we reduce ischemic cholangiopathy rates in donation after cardiac death liver transplantation after 10 years of practice? Canadian single-centre experience.
Tun-Abraham ME; Wanis K; Garcia-Ochoa C; Sela N; Sharma H; Al Hasan I; Quan D; Al-Judaibi B; Levstik M; Hernandez-Alejandro R
Can J Surg; 2019 Feb; 62(1):44-51. PubMed ID: 30484989
[TBL] [Abstract][Full Text] [Related]
17. Safety and Outcomes in 100 Consecutive Donation After Circulatory Death Liver Transplants Using a Protocol That Includes Thrombolytic Therapy.
Bohorquez H; Seal JB; Cohen AJ; Kressel A; Bugeaud E; Bruce DS; Carmody IC; Reichman TW; Battula N; Alsaggaf M; Therapondos G; Bzowej N; Tyson G; Joshi S; Nicolau-Raducu R; Girgrah N; Loss GE
Am J Transplant; 2017 Aug; 17(8):2155-2164. PubMed ID: 28276658
[TBL] [Abstract][Full Text] [Related]
18. Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study.
Hellemans R; Hazzan M; Durand D; Mourad G; Lang P; Kessler M; Charpentier B; Touchard G; Berthoux F; Merville P; Ouali N; Squifflet JP; Bayle F; Wissing KM; Noël C; Abramowicz D
Am J Transplant; 2015 Jul; 15(7):1923-32. PubMed ID: 25707875
[TBL] [Abstract][Full Text] [Related]
19. Polyclonal versus monoclonal induction therapy in a calcineurin inhibitor-free immunosuppressive therapy in renal transplantation: a comparison of efficacy and costs.
Sánchez-Escuredo A; Alsina A; Diekmann F; Revuelta I; Esforzado N; Ricart MJ; Cofan F; Fernandez E; Campistol JM; Oppenheimer F
Transplant Proc; 2015; 47(1):45-9. PubMed ID: 25645767
[TBL] [Abstract][Full Text] [Related]
20. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
Clark G; Walsh G; Deshpande P; Koffman G
Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
